Chandan Healthcare Ltd IPO
IPO Timeline
Category-wise Subscription
| Category | Sub (x) | Offered | Bid For | Amt (Cr)* |
|---|---|---|---|---|
| QIB | — | 3,082,400 (46%) | — | ₹4,901 Cr |
| NII (HNI) | — | 925,600 (14%) | — | ₹1,472 Cr |
| Retail | — | 2,159,200 (32%) | — | ₹3,433 Cr |
| Market Maker | — | 339,200 (5%) | — | ₹54 Cr |
| Σ Total | — | 6,752,000 (100%) | — | ₹107,357 Cr |
Only available investor categories are shown. Amount is auto-calculated when shares offered and issue price are available.
Issue Details
Minimum Investment (Lot-wise)
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 800 | ₹127,200 |
| Retail (Max) | 13 | 10,400 | ₹1,653,600 |
| S-HNI (Min) | 14 | 11,200 | ₹1,780,800 |
| B-HNI (Min) | 67 | 53,600 | ₹8,522,400 |
Financial Statements Amount in ₹ Crore
| Metric | 31 Dec 2024 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|
| Revenue | 168 | 178 | 137 |
| Profit After Tax | 17 | 16 | 4 |
| Net Worth | — | 41 | 27 |
| Total Assets | 170 | 129 | 98 |
| Reserves & Surplus | 34 | 21 | 7 |
| Total Borrowing | 52 | 42 | 21 |
Valuation & Key Ratios
Grey Market Premium (GMP)
GMP is an unofficial grey market indicator and does not guarantee actual listing price. Invest at your own risk.
Objects of the Issue
- Setting up a new Flagship Diagnostic Centre in Jankipuram, Lucknow, Uttar Pradesh. –
- Setting up a new Central Reference laboratory at Ayodhya, Uttar Pradesh –
- Setting up a new Central Reference laboratory at Ashiyana, Lucknow, Uttar Pradesh. –
- General corporate purposes. –
Company Overview
Incorporated in September 2003, Chandan Healthcare Limited runs diagnostic centres in North India with pathology and radiology testing services.
As of December 31, 2024, the company operates one flagship laboratory, seven central laboratories, and twenty-six satellite centres, with over three hundred collection centres in more than 23 cities across Uttar Pradesh and over 19 in Uttarakhand.
As of December 31, 2024, the company offers 1,496 tests across different specialities. The test menu includes
- 481 routine pathology tests in basic biochemistry and haematology, plus 1,015 specialised tests like immunohistopathology and molecular pathology, and
- 545 radiology tests, including x-rays, ultrasonography, CT, MRI, and specialised CT scans.
The radiology facilities have eleven CT scanners and four MRI machines.
As of December 31, 2024, the company employed 15 radiologists, 23 pathologists, and over 161 other qualified professionals.
Products and services:
The company primarily provides diagnostic services and ad hoc sales of consumables like X-ray films and reagents. Its subsidiary, Chandan Pharmacy Limited, operates medical stores offering a range of pharmaceutical products.
- Routine Pathology Tests
- Specialized Pathology Tests
- Radiology Tests
- Preventive and Wellness Services
- Home Collection Service
Competitive Strength:
- Strong geographic presence in Uttarakhand, including 39 tier-two cities and towns.
- Integrated diagnostics provider offering pathology, radiology testing, and medical consultations.
- Track record of profitability and consistent financial performance.
- Dedicated management team with significant industry experience.